HIV/AIDS, TB, malaria, health and medical
Results are sorted by date modified.
LifeSpring Hospital in India is innovatively meeting the growing demand of low-income women who deserve affordable and dignified medical care. By focusing on a particular niche, maternal care, and different cost-saving strategies, this hospital provides maternal care at one-fifth of market...
In April 2010 the Heineken Africa Foundation approved the first project in Namibia to support the provision of mobile primary health care in rural Namibia. Funding was provided for the purchase of three mobile clinics and the support for implementation of a mobile health service programme by 2013....
In rural Mali, Miama sells rice to support her family, thanks to both a microloan and the group support she receives from Freedom from Hunger's Benkadi Tongorongo association.
To reach populations in remote areas, Hindustan Unilever has recruited and trained women in rural areas to act as direct sales operators. This led to the creation of Project Shakti in India which is now being extended to other countries as well.
FINISH is an action research project set up by UNU-MERIT a research and training centre of the United Nations University in Holland, working in close collaboration with the University of Maastricht.
In several African countries, such as Ethiopia, Uganda, Zambia and Malawi, Bayer has participated actively in the fight against malaria.
In 2005, in conjunction with Bayer AG, the TB Alliance launched an historic clinical trial program to test whether Bayer's moxifloxacin can be used to significantly shorten the time it takes to cure TB.
Barclays and Citigroup participate in NGO-corporate partnerships to support vulnerable children in rural Kenya
Under an initiative led by Pathfinder and Barclays Bank of Kenya, Ltd., the Kabras Jua Kali Association (KJKA) runs a program for orphans and vulnerable childred (OVC) aged 15 to 21 years.
Pfizer Slovakia decided to support League for Mental Health in the development of art-therapy, through the project “Searching for a talent”.
In partnership with Drugs for Neglected Diseases initiative (DNDi), Sanofi-aventis has developed ASAQ, the first once-a-day fixed-dose antimalarial combination drug.
In April 2005, Sanofi-aventis signed an agreement with Drugs for Neglected Diseases initiative (DNDi) to develop a new medicine against malaria, in response to a call from the World Health Organization (WHO) for malaria be treated by drug combinations to combat resistance.